Unlock instant, AI-driven research and patent intelligence for your innovation.

Combination Of Leucine Source And Omega-3 Unsaturated Fatty Acid Source For Prophylactic Or Therapeutic Treatment Of Hypercalcaemia

A technology of unsaturated fatty acids and hypercalcemia, applied in the field of combination of leucine source and omega-3 unsaturated fatty acid source for the treatment of hypercalcemia, capable of solving problems such as lack of specificity

Inactive Publication Date: 2015-01-07
NV NUTRICIA
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, no experimental results were shown specifically for the treatment of subjects with hypercalcemia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Combination Of Leucine Source And Omega-3 Unsaturated Fatty Acid Source For Prophylactic Or Therapeutic Treatment Of Hypercalcaemia
  • Combination Of Leucine Source And Omega-3 Unsaturated Fatty Acid Source For Prophylactic Or Therapeutic Treatment Of Hypercalcaemia
  • Combination Of Leucine Source And Omega-3 Unsaturated Fatty Acid Source For Prophylactic Or Therapeutic Treatment Of Hypercalcaemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0100] Example 1: Inhalation formulation example

[0101] Table 1: Nutrient Composition for Suction Feeding

[0102]

Embodiment 2

[0103] Example 2: Tube Feeding Formulation Example

[0104] Table 2: Nutrient Composition for Tube Feeding

[0105]

Embodiment 3

[0106] Embodiment 3 test result

[0107] Materials and methods

[0108] animal

[0109] Male CD2F1 mice (BALB / c x DBA / 2, Harlan / Charles River, Netherlands) aged 6-7 weeks were individually housed in a temperature-controlled room (12:12 light-dark cycle, constant room temperature of 21±1°C) . After one week of acclimatization, the mice were divided into weight-matched groups: (1) a control group receiving a control diet, (2) a tumor-bearing group receiving a control diet, and (3) a tumor-bearing group receiving an experimental diet. The data shown are from the combination of several experimental sessions with the same animal characteristics and experimental procedures (unless otherwise stated) and differ only by the experimental diet employed. All experimental procedures were approved by the Animal Ethics Committee (DEC Committee, Bilthoven, The Netherlands) and followed principles of good laboratory animal care.

[0110] Experimental Diets (Type A and Type B Experiments) ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a combination of a leucine source and at least one unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia. The invention further relates to a combination of a leucine source and at least one unsaturated fatty acid source for reducing or avoiding a reduction in bone mineral density in a subject or for in vivo regulating of the blood plasma calcium homeostasis.

Description

[0001] The present invention is a divisional application of the application date of May 27, 2010, the title of the invention is "the combination of leucine source and omega-3 unsaturated fatty acid source for the treatment of hypercalcemia", and the application number is 201080033424.8 . technical field [0002] The present invention relates to specific combinations of at least two components for use in the treatment of hypercalcaemia, for reducing or avoiding a decrease in bone mineral density in a subject, or for regulating plasma calcium homeostasis in vivo. Background technique [0003] Calcium plays an important role in many different physiological functions, especially the conversion of excitatory stimuli to nerve and muscle tissue. In addition, calcium is involved in signaling pathways that can, for example, lead to changes in hormone balance (eg cholecystokinin balance). In healthy individuals, plasma calcium homeostasis is tightly regulated and maintained within na...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/198A61K45/06A61K31/202A61K31/702A23L1/305A23L1/09A61P3/14A61P1/14A61P1/08A61P39/00
CPCA23V2002/00A61K31/702A61K38/02A61K31/202A23L1/3051A23L1/3008A61K31/198A61K31/715A23L1/305A61K45/06A61K2300/00A23L33/12A23L33/17A23L33/175A61P1/08A61P1/14A61P19/08A61P3/02A61P3/04A61P3/14A61P35/00A61P39/00A61P7/00
Inventor 克拉斯克·范诺伦霍伊塞·法贝尔阿德里安乌斯·拉姆贝图斯·贝特霍尔德斯·范赫尔福尔特罗伯特·约翰·约瑟夫·哈格曼
Owner NV NUTRICIA